But now Pfizer is betting that a radical new adult stem-cell treatment may be able to stave off diabetes-induced retina damage, a leading cause of blindness.
Some areas identified as particularly human are the regulation of the cone cells of the retina (which are involved in colour vision) and the regulation of nerve-cell growth.